Marta L Stamwitz, LCSW | |
19964 Hilltop Rd Ste A, Parker, CO 80134-7316 | |
(303) 841-2212 | |
(303) 841-4716 |
Full Name | Marta L Stamwitz |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 19964 Hilltop Rd Ste A, Parker, Colorado |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134434582 | NPI | - | NPPES |
100073590 | Medicaid | IN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | (* (Not Available)) | Secondary |
1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
Entity Name | Poudre Valley Medical Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366763260 PECOS PAC ID: 9638208549 Enrollment ID: O20100602000122 |
News Archive
Many people get on with their lives after traumatic experiences without any psychological suffering. This is because, in spite of all the trauma, they manage to pigeonhole what they have experienced. Although this sense of coherence was first described in the 1970s, measuring it has remained problematic to this day.
"Our study shows that poor mental health in children and teenagers has a large impact on the length of time they will stay in school," says Dr. Lehrer. He notes a large number of school-based programs have recently been introduced to prevent childhood obesity through lifestyle changes, but suggests the net should be cast more widely. "It's important for policymakers to target health conditions that are not the easiest to identify - like inattention - but may have larger impacts on one's future."
Reluctantly yielding to a federal-court decision, the Obama administration announced on Monday that it will take steps to allow a version of the so-called morning-after pill, known as Plan B One-Step, to be sold over the counter to girls and women of all ages. They will not need a prescription, nor will they be required to show any identification to obtain the emergency contraceptive. There will be no restrictions on where the drug can be sold; it will be up to the manufacturer to propose appropriate venues (6/11).
A translational research project supported by the National Foundation for Cancer Research (NFCR) has been awarded $700,000 from Virginia Catalyst to advance its lead cancer drug candidate.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Marta L Stamwitz, LCSW 2695 Rocky Mountain Ave Ste 150, Loveland, CO 80538-9071 Ph: (970) 624-4123 | Marta L Stamwitz, LCSW 19964 Hilltop Rd Ste A, Parker, CO 80134-7316 Ph: (303) 841-2212 |
News Archive
Many people get on with their lives after traumatic experiences without any psychological suffering. This is because, in spite of all the trauma, they manage to pigeonhole what they have experienced. Although this sense of coherence was first described in the 1970s, measuring it has remained problematic to this day.
"Our study shows that poor mental health in children and teenagers has a large impact on the length of time they will stay in school," says Dr. Lehrer. He notes a large number of school-based programs have recently been introduced to prevent childhood obesity through lifestyle changes, but suggests the net should be cast more widely. "It's important for policymakers to target health conditions that are not the easiest to identify - like inattention - but may have larger impacts on one's future."
Reluctantly yielding to a federal-court decision, the Obama administration announced on Monday that it will take steps to allow a version of the so-called morning-after pill, known as Plan B One-Step, to be sold over the counter to girls and women of all ages. They will not need a prescription, nor will they be required to show any identification to obtain the emergency contraceptive. There will be no restrictions on where the drug can be sold; it will be up to the manufacturer to propose appropriate venues (6/11).
A translational research project supported by the National Foundation for Cancer Research (NFCR) has been awarded $700,000 from Virginia Catalyst to advance its lead cancer drug candidate.
› Verified 9 days ago